Related Experiment Video
Updated: Apr 20, 2026

Author Spotlight: Exploring Metabolic and Aging Processes in C. elegans Using Low-Cost, High-Impact Assays
Published on: February 23, 2024
pH-responsive dietary fiber microspheres with programmed structural evolution in the gastrointestinal tract
Kaiyang Ma1, Xinxin Song2, Cong Teng1
1Institute of Agro-product Processing, Jiangsu Academy of Agricultural Sciences, Nanjing, 210014, China.
None:
The structural transformation of dietary fiber within the gastrointestinal tract critically determines its efficacy in alleviating functional constipation (FC). This study explored the structural evolution of pH-responsive burdock root dietary fiber microspheres (BDFRM) in gastrointestinal environments and anti-constipation molecular mechanisms. In vitro digestion showed BDFRM maintained structural integrity in simulated gastric fluid but exhibited targeted swelling in simulated intestinal fluid (expansibility is 13.52 ± 0.10 mL/g), with a swelling ratio 2-fold higher than in SGF (expansibility is 6.82 ± 0.09 mL/g), and demonstrated superior water-holding capacity in simulated colonic fluid. In loperamide-induced constipated ageing rats, BDFRM significantly improved fecal parameters including weight-to-body ratio and moisture, accelerated intestinal transit, and shortened first black stool time (p < 0.05). It increased the concentration of Gas and MTL, inhibited VIP in serum, and enhanced the mRNA levels of c-Kit and ACh in intestine tissue. Meanwhile, BDFRM repaired mucosal injury, suppressed the mRNA levels of inflammatory factors, upregulated the mRNA expression level of tight junction proteins, and activated the Nrf2 pathway. Thus, BDFRM's site-specific structural changes multidimensionally enhance intestinal peristalsis. This study provides a promising targeted dietary strategy for managing FC in the ageing population and a practical approach for developing functional foods from dietary fiber.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...

